Company Filing History:
Years Active: 2014
Title: Brigit A De Jong: Innovator in Inflammatory Disease Prognostics
Introduction
Brigit A De Jong is a prominent inventor based in Nijmegen, Netherlands. She has made significant contributions to the field of medical science, particularly in the area of inflammatory diseases. Her innovative work focuses on improving patient care through better prognostic classification.
Latest Patents
Brigit A De Jong holds a patent for "Markers for determination of patient responsiveness." This invention provides compositions and methods for the prognostic classification of inflammatory diseases, such as inflammatory demyelinating diseases. The patent outlines how specific cytokine patterns can identify patients likely to benefit from therapeutic interventions. It also helps to distinguish between patients with high and low probabilities of responsiveness to therapy. This assessment allows for improved methods of care, particularly for autoimmune diseases like multiple sclerosis and neuromyelitis optica. She has 1 patent to her name.
Career Highlights
Brigit A De Jong is affiliated with Leland Stanford Junior University, where she continues her research and development in the medical field. Her work has garnered attention for its potential to enhance treatment strategies for patients suffering from inflammatory diseases.
Collaborations
Brigit has collaborated with notable colleagues, including Robert C Axtell and Lawrence Steinman. These partnerships have contributed to the advancement of her research and the impact of her inventions.
Conclusion
Brigit A De Jong is a trailblazer in the field of inflammatory disease prognostics, with her innovative patent paving the way for improved patient care. Her contributions are vital in the ongoing quest to enhance therapeutic outcomes for patients.